⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28397952 | 0.78 | GSK3A (0.34) | — | |
| SCHEMBL24787879 | 0.60 | MCL1 (0.31) | — | |
| SCHEMBL12266886 | 0.58 | GAA (0.33) | — | |
| SCHEMBL30368181 | 0.57 | TSHR (0.39) | — | |
| SCHEMBL7363919 | 0.57 | — | — | |
| SCHEMBL18599678 | 0.57 | ALDH1A1 (0.31) | — | |
| SCHEMBL28818565 | 0.57 | ALDH1A1 (0.30) | — | |
| SCHEMBL16614389 | 0.56 | NFKB1 (0.41) | — | |
| SCHEMBL9477538 | 0.55 | TSHR (0.32) | — | |
| SCHEMBL19483225 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6605631-B1 | Controlling fungi and pests; improved activity and plant tolerability | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-12 | — | — | US | disclosed |
| US-6031110-A | Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-29 | — | — | US | disclosed |
| CN-1046275-C | 2-methoxyiminophenyl-N-methylacetamide derivatives, process for their preparation, their use and compositions containing them | BASF AG (DE) | 1999-11-10 | — | — | CN | disclosed |
| EP-0757042-A1 | Ortho-substituted 2-methoxyiminophenylaceticacid methylester | BASF Aktiengesellschaft (DE) | 1997-02-05 | — | — | EP | disclosed |
| CN-1118165-A | Ortho-substituted 2-methoxyiminophenylacetic acid methylamides | BASF AG (DE) | 1996-03-06 | — | — | CN | disclosed |